Derrick Robertson

Statistics

Publications

Citations

2.8K

H-Index

Active since

1977

Affiliations

University of South Florida(Current)

Cleveland Clinic

Montreal Neurological Institute and Hospital

University of California, San Francisco

Heinrich Heine University Düsseldorf

Derrick Robertson is an author at University of South Florida specializing in multiple sclerosis, multiple sclerosis pharmacotherapy, and multiple sclerosis therapy.

ORCID

Publications per year

1977–2025

Publications

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 925 citations

Medicine, Neurology, Pharmacology +9

Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis

Amit Bar‐Or, Jonathan Calkwood, Cathy Chognot et al. · Neurology · 2020 · 339 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Raju Kapoor, Pei‐Ran Ho, Nolan Campbell et al. · The Lancet Neurology · 2018 · 337 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

LOW-DOSE HEPARIN AS A PROPHYLAXIS AGAINST DEEP-VEIN THROMBOSIS AFTER ACUTE STROKE

Sharon McCarthy, Derrick Robertson, J.J Turner et al. · The Lancet · 1977 · 200 citations

Medicine, Hematology, Pharmacotherapy +10

Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis

Lawrence Steinman, Edward Fox, Hans‐Peter Hartung et al. · New England Journal of Medicine · 2022 · 199 citations

Life Sciences, Immunology, Pharmacotherapy +17

1–5 of 19